Photo: Cavan/Adobe StockTwo dogs with metastatic, multicentric diffuse large B cell lymphoma have gone into remission after receiving human CAR-T cell therapy. In an announcement on the news, Akadeum said the treatment’s success could have important implications for cancer research, as it shows LEAH Labs can engineer and track human CAR-T cells in vivo. For the treatment, Lou, a 10-year-old Beagle, and Sadie, an 8-year-old Collie/Pyrenees mix received infusion with CAR-T cells isolated with Akadem’s kit. Related: New cancer study aims to help both animals and humans2Positron emission tomography imaging further showed that the gene-edited CAR-T cells could be visualized in injected lymph nodes. “Akadeum's microbubble-based kits are known for isolating more viable, healthier T cells, enabling the work done by LEAH Labs.